E. Derkach

METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY

N. Avxentyev, E. Derkach, E. Pyadushkina, 2016 .

Socio-economic impact of heart failure in Russia

S. Boytsov, O. Drapkina, A. Kontsevaya, 2021, Russian Journal of Cardiology.

Pharmacoeconomic evaluation of using enzalutamide for treatment of patients with metastatic hormone-sensitive prostate cancer

Y. Makarova, N. Avxentyev, E. Derkach, 2022, Cancer Urology.

Carcinosarcoma of the Gallbladder: A Rare Tumor

Safi Khuri, Subhi Mansour, E. Derkach, 2022, World journal of oncology.

Economic analysis of aflibercept in wet age-related macular degeneration

E. Derkach, K. Gerasimova, I. Loskutov, 2016 .

Economic evaluation of doravirine/tenofovir disoproxil fumarate/lamivudine for HIV-1-infected adults in Russia: a cost-minimization and budget impact analysis

D. Ugrekhelidze, E. Derkach, A. Beyer, 2022, Expert review of pharmacoeconomics & outcomes research.

Drugs influencing on PCSK9 activity: modelling of efficacy in patients who had myocardial infarction with uncontrolled dyslipidemia

A. Kontsevaya, E. Derkach, V. Ignatyeva, 2023, Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice.